Skip to main content
. 2022 Jul 6;12:11461. doi: 10.1038/s41598-022-15630-8

Table 2.

Comparison of cognition and other non-motor symptoms in de novo Parkinsonian patients with or without MCI.

Variable MCI Non-MCI P value
K-MMSE, score 24.4 ± 4.4 27.3 ± 2.1 0.0015
Cognitive subdomain (composite %ile)
Attention and working memory 79.7 ± 21.3 80.0 ± 19.3 0.945
Language 41.4 ± 33.0 68.6 ± 19.0  < 0.001
Memory 13.3 ± 19.1 47.8 ± 23.9  < 0.001
Visuospatial function 32.5 ± 29.6 59.7 ± 30.0  < 0.001
Executive function 18.5 ± 21.0 54.7 ± 26.3  < 0.001
BDI (depression) 12.9 ± 9.1 6.9 ± 5.1 0.015
BAI (anxiety) 8.0 ± 6.8 5.9 ± 6.1 0.380
PFS (fatigue) 45.7 ± 17.6 38.2 ± 14.9 0.473
SCOPA-AUT (dysautonomia)
Gastrointestinal (GI) domain 4.5 (2–7) 1 (0–3) 0.003a
Urinary (UR) domain 8.5 (5.25–11.75) 4 (2.25–6) 0.005a
Cardiovascular (CV) domain 1 (0–2) 0 (0–0) 0.005a
Thermoregulatory (TR) domain 1 (0–2) 0 (0–0.75) 0.047a
Pilomotor (PM) domain 0 (0–0) 0 (0–0) 0.520a
Total dysautonomia 17.1 ± 8.4 9.0 ± 6.5  < 0.001

Data are shown as mean ± S.D., or median (interquartile range) values.

MCI, mild cognitive impairment; K-MMSE, Korean version of mini-mental state examination; BDI, Beck depression inventory; BAI, Beck anxiety inventory; PFS, Parkinson’s disease fatigue scale; SCOPA-AUT, the Scale for Outcomes in Parkinson’s disease-Autonomic questionnaire.

Statistical analyses were conducted with Chi square test for categorical variables, and Student t-test or Mann–Whitney U test afor continuous variables.

Significant values are in bold.